What You Should Know:
– AnswersNow, the leader in virtual Applied Behavioral Analysis (ABA) therapy, today announced that it has raised $40 million in Series B funding led by HealthQuest Capital, with participation from existing investors Left Lane Capital, Owl Ventures, and others.
– AnswersNow delivers clinically proven outcomes in one-sixth the hours of traditional therapy, creating substantial cost savings for payors while delivering superior results for families.
AnswersNow Scales AI-Enabled Virtual ABA to Redefine Access, Outcomes, and Economics in Autism Care
AnswersNow is transforming the autism therapy experience by increasing the immediacy, accessibility, and quality of care through personalized, virtual Applied Behavioral Analysis (ABA). The company’s AI-powered platform generates individualized learning modules that adapt to each child’s interests and engagement patterns, enabling a national network of PhD- and Master’s-level Board-Certified Behavior Analysts (BCBAs) to deliver superior outcomes with approximately five hours of weekly therapy—rather than the 30+ hours typical of traditional, in-person models. AnswersNow operates across multiple states with in-network coverage through commercial insurers and Medicaid, delivering up to a 75% reduction in total care costs while improving family satisfaction.
Newly raised capital will be used to accelerate platform and team expansion to meet growing demand for autism support services. The company plans to double its clinical staff, add senior leadership, and launch new service offerings in the coming months, while continuing to invest in artificial intelligence capabilities that drive personalization, scalability, and operational efficiency.
AnswersNow’s care model centers on highly personalized 1:1 virtual therapy, connecting families with BCBAs regardless of geography. Clinical results demonstrate significant improvements in Vineland Adaptive Behavior Scales within six months using just four to five hours of therapy per week—achieving outcomes comparable to or better than traditional approaches that require substantially more time. This reduction in therapy hours translates into meaningful system-level savings of up to 75% for commercial payors and Medicaid plans, improving the financial sustainability of evidence-based autism care.
“The data show that by exclusively using Master’s- and PhD-level BCBAs for targeted parent training, combined with AI-enabled, focused therapy for children, we can achieve equal or better outcomes at a fraction of the time and cost,” said Jeff Beck, CEO of AnswersNow. “This model makes proven autism therapy more accessible for families and economically viable for payors.”
A core differentiator is AnswersNow’s proprietary AI platform, which continuously adapts therapy content to each child’s natural affinities and motivation drivers. By aligning sessions with what engages each child, clinicians see faster skill acquisition, stronger generalization to real-world settings, and sustained progress with fewer total therapy hours.
In 2025 alone, AnswersNow facilitated nearly 100,000 hours of virtual ABA therapy and caregiver training. Its parent-mediated model—delivered exclusively by BCBAs—extends therapeutic impact beyond scheduled sessions by equipping caregivers to reinforce skills during everyday interactions. Within the first six months of care, 96% of families report meaningful improvements in behavior and communication, children demonstrate clinically significant gains on standardized assessments despite reduced therapy hours, payors realize up to a 75% reduction in total autism care costs, and the company has maintained a Net Promoter Score of 83 (N=170).
Looking ahead, AnswersNow plans to publish first-of-its-kind research in early 2026 documenting its clinical outcomes and efficiency at scale, further validating a model that is reshaping autism care delivery while aligning quality, access, and affordability for families and the healthcare system.
